Philadelphia-based Passage Bio is a fully integrated gene therapy company. Founded by James Wilson in 2018, Passage Bio is backed by investors that include Frazier Healthcare Partners, Lilly Asia Ventures, OrbiMed, Versant Ventures, and Vivo Capital.